About Kaleido
Kaleido is a Healthcare company based in Utrecht (Netherlands) founded in 2013 by Tim Oakes. Insulin pumps and monitoring software for diabetes are developed. It operates on a HealthTech and Direct-to-Consumer (D2C) model. Kaleido has raised $183.29 million across 5 funding rounds from investors including EQT, Kreos Capital and Life Sciences Partners. Its chief executive, as recorded, is Thomas Arnold. Kaleido offers products and services including Kaleido Insulin Pump and DBLG1 Hybrid Closed Loop System. Its focus areas include Medical Devices and Diabetes Management. Its legal entity is ViCentra B.V.
Company details
Kaleido, operated by ViCentra B.V., is dedicated to providing advanced diabetes management solutions through its innovative insulin pump technology. The company offers the Kaleido Insulin Pump, designed for flexibility with customizable wear options and integrated with the DBLG1 Hybrid Closed Loop system for automated insulin delivery. Serving the healthcare sector, particularly in diabetes care, Kaleido emphasizes user freedom and personalized care with features like self-learning algorithms and 247 data insights. Its solutions are currently available in the Netherlands and Germany, targeting adults with type 1 diabetes.
- Headquarters Utrecht, Netherlands
- Founders Tim Oakes
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website hellokaleido.com
- Social LinkedIn X Facebook YouTube
- Legal Name Vicentra B.V.
- Total Equity Funding$183.29M (USD)
in 5 rounds
- Latest Funding Round$13M (USD), Series D
Jan 2026
- InvestorsEQT
& 12 more
Products & Services of Kaleido
Kaleido offers a comprehensive portfolio of products and services, including Kaleido Insulin Pump and DBLG1 Hybrid Closed Loop System.
Insulin pump designed for flexible diabetes management daily.
System integrated for automated insulin delivery control.
Apps and channels of Kaleido
its YouTube channel Kaleido has 495 subscribers and 30 videos.
Videos from Kaleido
The most watched videos on Kaleido's YouTube channel, Kaleido (495 subscribers). Click a video to play it here.
More on Kaleido.
Funding Insights of Kaleido
Kaleido has successfully raised a total of $183.29M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $13 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $183.29M
- Total Rounds 5
- Last Round Series D — $13M
- Investors Count 13
All 5 funding rounds of Kaleido with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2026 | $13M | Series D | – | – | |
| Sep 2025 | $85M | Series D | – | Innovation Industries | |
| Dec 2021 | $74M | Series C | – | Partners in Equity | |
| Jun 2020 | $11.29M | Series B | – | Invest-NL | |
| Jan 2016 | Series B | – | Life Sciences Partners, Inkef Capital | – |
13 investors in total: 13 institutional.
Investors in Kaleido
Kaleido has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include EQT, Kreos Capital and Life Sciences Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Partners in Equity is focused on impact investments for environmental solutions. | 2003 | pi-equity.com | Amsterdam, Netherlands | |
Private equity investments in life sciences businesses are managed. | 1998 | lspvc.com | Amsterdam, Netherlands | |
AI, deeptech, and healthcare tech companies are funded by Inkef. | inkef.com | Amsterdam, Netherlands | ||
Infrastructure and venture capital funding is provided in key sectors. | invest-nl.nl | Amsterdam, Netherlands | ||
Venture debt is provided to growth-stage companies across multiple sectors. | 1998 | kreoscapital.com | London, United Kingdom | |
Health Innovations is focused on investing in healthcare improvements. | 2007 | healthinnovations.nl | Netherlands | |
Early & late stage VC firm investing primarily in Netherlands | inkefcapital.com | Amsterdam, Netherlands | ||
A European venture capital fund focused on deep tech investments. | innovationindustries.com | Amsterdam, Netherlands | ||
An impact investment firm focused on environmental sustainability. | 2003 | partnersinequity.com | Amsterdam, Netherlands | |
EQT is recognized as a global investment organization focused on value creation. | 1994 | eqtgroup.com | Stockholm, Sweden |
Investor details for Kaleido
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Kaleido
9 people are tracked at Kaleido (4 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Tim Oakes | Co-Founder & CTO | Leadership |
Thomas Arnold | CEO | Leadership |
Guido Mitchell | VP Of Commercial | Leadership |
Alex Puiu | Head Of Clinical Affairs | Leadership |
Gerard Roeplall | Account Manager Medical Devices NL | Team |
Femke Reijmer | Accountmanager | Team |
Marlon Jacobs | Kaleido Accountmanager | Team |
Begüm Edek | Senior Quality Engineer | Team |
Marijke Warren | Project Lead Quality | Team |
Complete people profiles for Kaleido
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Kaleido
3 dated milestones of Kaleido across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Kaleido is founded.
- Funding First funding round.
- Funding Latest funding round, Series D, of $13.0M.
Web traffic of Kaleido
The website of Kaleido (hellokaleido.com) receives about 6.7K visits a month.
- Monthly visits6.7K
▼ 3.7% vs previous month
Websites whose visitors overlap most with Kaleido. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| dvn.nl | 100% | 56.3K | #684,280 | View details | |
| mylife-diabetescare.com | 95% | #596,964 | View details | ||
accu-chek.de | accu-chek.de | 95% | #317,208 | – | |
| omnipod.com | 95% | #42,515 | View details | ||
bosman.com | bosman.com | 63% | #444,579 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Kaleido
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kaleido
Complete news archive for Kaleido
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kaleido
Kaleido was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Kaleido is headquartered in Utrecht, Netherlands.
Thomas Arnold is the CEO of Kaleido, as recorded in our data.
Kaleido is a funded company, having raised a total of $183.29M across 5 funding rounds to date.
Kaleido, operated by ViCentra B.V., is dedicated to providing advanced diabetes management solutions through its innovative insulin pump technology. The company offers the Kaleido Insulin Pump, designed for flexibility with customizable wear options and integrated with the DBLG1 Hybrid Closed Loop system for automated insulin delivery. Serving the healthcare sector, particularly in diabetes care, Kaleido emphasizes user freedom and personalized care with features like self-learning algorithms and 247 data insights. Its solutions are currently available in the Netherlands and Germany, targeting adults with type 1 diabetes.
Kaleido offers Kaleido Insulin Pump and DBLG1 Hybrid Closed Loop System.
Kaleido has 13 investors. Key investors include EQT, Kreos Capital, Life Sciences Partners, Partners in Equity, and Direct Recruiters.
Kaleido operates through Vicentra B.V..